Literature DB >> 19070593

Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice.

Reiko Tanaka1, Yoshikazu Miwa, Kin Mou, Morimasa Tomikawa, Naomi Eguchi, Yoshihiro Urade, Fumi Takahashi-Yanaga, Sachio Morimoto, Norio Wake, Toshiyuki Sasaguri.   

Abstract

This study was designed to determine whether lipocalin type-prostaglandin D synthase (l-pgds) deficiency contributes to atherogenesis using gene knockout (KO) mice. A high-fat diet was given to 8-week-old C57BL/6 (wild type; WT), l-pgds KO (LKO), apolipoprotein E (apo E) KO (AKO) and l-pgds/apo E double KO (DKO) mice. The l-pgds deficient mice showed significantly increased body weight, which was accompanied by increased size of subcutaneous and visceral fat tissues. Fat deposition in the aortic wall induced by the high-fat diet was significantly increased in LKO mice compared with WT mice, although there was no significant difference between AKO and DKO mice. In LKO mice, atherosclerotic plaque in the aortic root was also increased and, furthermore, macrophage cellularity and the expression of pro-inflammatory cytokines such as interleukin-1beta and monocyte chemoattractant protein-1 were significant increased. In conclusion, l-pgds deficiency induces obesity and facilitates atherosclerosis, probably through the regulation of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070593     DOI: 10.1016/j.bbrc.2008.11.152

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects.

Authors:  Shinrye Lee; Eunha Jang; Jong-Heon Kim; Jae-Hong Kim; Won-Ha Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.

Authors:  Nathalie Pamir; Timothy S McMillen; Kimberly A Edgel; Francis Kim; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 4.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

Review 5.  Prostaglandins and inflammation.

Authors:  Emanuela Ricciotti; Garret A FitzGerald
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05       Impact factor: 8.311

6.  Unexpected role of lipocalin-type prostaglandin D synthase in brain: regulation of glial cell migration and morphology.

Authors:  Kyoungho Suk
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

7.  Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase.

Authors:  Takashi Kumasaka; Kosuke Aritake; Hideo Ago; Daisuke Irikura; Toshiharu Tsurumura; Masaki Yamamoto; Masashi Miyano; Yoshihiro Urade; Osamu Hayaishi
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

8.  Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.

Authors:  Daisuke Irikura; Kosuke Aritake; Nanae Nagata; Toshihiko Maruyama; Shigeru Shimamoto; Yoshihiro Urade
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

9.  Prostaglandins as PPARγ Modulators in Adipogenesis.

Authors:  Ko Fujimori
Journal:  PPAR Res       Date:  2012-12-25       Impact factor: 4.964

10.  Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo.

Authors:  Sam Virtue; Mojgan Masoodi; Vidya Velagapudi; Chong Yew Tan; Martin Dale; Tapani Suorti; Marc Slawik; Margaret Blount; Keith Burling; Mark Campbell; Naomi Eguchi; Gema Medina-Gomez; Jaswinder K Sethi; Matej Orešič; Yoshihiro Urade; Julian L Griffin; Antonio Vidal-Puig
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.